The novel protein named haditoxin has been described in the prestigious Journal of Biological Chemistry (March 12, 2010).
The editorial board of the journal has selected this work as the "Paper of the Week" recognising it as being in the top one per cent of their published articles in terms of significance and overall importance.
Haditoxin was discovered in Professor Manjunatha Kini's laboratory at the National University of Singapore. Co-author of the paper Dr S. Niru Nirthanan, now at Griffith University on the Gold Coast, has characterised the pharmacological actions of haditoxin.
Dr Nirthanan said that haditoxin was structurally unique and therefore expected to have unique pharmacological properties.
"This toxin is like a conjoined twin. It is a relatively large complex made up of two identical protein molecules known as three-finger toxins linked together."
"We know that the family of three-finger toxins display diverse biological actions on the human nervous system, cardiovascular system and blood clotting. Some have directly led to the development of compounds with potent analgesic and blood pressure reducing properties – so it is likely that haditoxin in its 'conjoined twin' state or as individual components will offer us more novel insights," he said.
Dr Nirthanan, a former clinician who has research interests in pharmacology and neurobiology, said many common drugs such as the widely prescribed blood pressure medication Captopril and anti-clotting drug Eptifibatide have been developed from snake and other animal venoms.
"Researchers have been studying King Cobra venom for over 50 years and yet we are still identifying new compounds. It is a complex cocktail of biological molecules that can change composition depending on the environment, the season or even the snake's diet."
The venom primarily acts on neurotransmitter receptors which regulate communication between nerve cells or between nerves and muscles, resulting in symptoms such as paralysis and respiratory failure. /more
He said that from a clinical perspective, the worldwide burden of snakebite is high with up to 125,000 preventable deaths each year and significant public health costs associated with snakebite treatment.
"We may be able to improve management of snakebite as we better understand the mechanism of action of these venoms. However, my research interest is in the therapeutic and pharmacological potential of venom toxins."
While not every new toxin will convert directly into a clinically useful drug, he said there was potential for haditoxin to be a lead compound or template from which to design other drugs. "Because of the high specificity of these toxins, haditoxin may also be useful as a 'molecular probe' which will help us study neurotransmitter receptors and their role in disease."
These receptors are important in neurodegenerative conditions such as Alzheimer's and Parkinson's diseases as well as in schizophrenia, anxiety and depressive disorders and nicotine addiction.
The haditoxin research was conducted by an international team from the National University of Singapore, Griffith University and University of Geneva.
High resolution photos of Dr Niru Nirthanan and haditoxin available for download at https://www79.secure.griffith.edu.au/oer-images/Niru
MEDIA CONTACTS: Dr Niru Nirthanan 07 5552 8231 or Health Communications Officer Mardi Chapman 07 5552 9089, 0408 727 706
Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory
Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
09.12.2016 | Ecology, The Environment and Conservation
09.12.2016 | Health and Medicine